Back to Ask the Diabetes Team Ask the Diabetes Team

From Herndon, Virginia, USA:

My eight year old daughter was diagnosed with type 1 diabetes three months ago. We just switched endocrinologists, and they seem to have different views on injection site rotation. The first doctor had my daughter on a two shot per day regimen of NPH with NovoLog had my daughter do her injections focusing on one body part at a time (using sites on that body part then moving to the next -- thighs, stomach, arms). I think his goal was to maximize the time between injections in the same location. However, the new doctor has switched her to a three shot per day regimen with (NPH with NovoLog in the morning, NovoLog at dinner, and NPH before bed) and emphasizes keeping the injection in the same body part for each injection to get consistent absorption (i.e. evening and morning NPH in thighs, and dinner NovoLog in arms). Can you comment on these different approaches?


If forced to pick, I'd side with endocrinologist number two. There is evidence that absorption is fastest from the abdomen, then the arms then the thighs. This knowledge suggests that one of the many variables of insulin absorption can be minimised by sticking with a combination of injection time and body part. Provided that the actual site within the region is also varied, injection site lipohypertrophy can be avoided.


Original posting 3 Aug 2003
Posted to Blood Tests and Insulin Injections


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: Tuesday April 06, 2010 15:09:48
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.